|
End-of-day quote
Berne S.E.
28/08/2026
|
5-day change | 1st Jan Change | ||
| 132.24 CHF | +0.75% |
|
-0.17% | -8.71% |
| 06:53pm | IDEAYA Biosciences Plans Phase 3 Trial for Lung Cancer Therapy | MT |
| 03:39pm | Hutchmed Says Lung Cancer Therapy Improves Progression-Free Survival in China Phase 3 Trial | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.70% | -7.36% | +0.55% | +6.74% | +7.49% | +57.12% | +108.44% | +347.23% | +1,385.74% | 1,047B | |
| -0.69% | -2.48% | +3.87% | +19.14% | +28.67% | +49.55% | +64.70% | +53.80% | +123.13% | 646B | |
| +0.61% | -2.99% | +2.26% | +20.51% | +12.31% | +21.09% | +74.61% | +112.46% | +300.33% | 451B | |
| -1.64% | -4.75% | -0.23% | +11.15% | +7.50% | +35.59% | +35.54% | -4.07% | +47.12% | 355B | |
| -0.39% | -2.76% | -2.64% | +8.22% | +12.46% | +21.39% | +38.01% | +45.37% | +59.25% | 291B | |
| -1.19% | -2.21% | -5.90% | -13.27% | -13.20% | +1.53% | +11.51% | +39.75% | +139.30% | 252B | |
| -0.55% | -3.05% | +11.72% | +30.74% | +31.46% | +49.97% | +67.86% | +90.79% | +153.03% | 234B | |
| -1.05% | -2.29% | -4.60% | +2.63% | -10.10% | -19.91% | -54.10% | -6.83% | +87.02% | 203B | |
| +0.50% | -0.31% | +12.35% | +11.59% | +19.19% | +29.79% | +91.28% | +101.00% | +86.64% | 181B | |
| +2.06% | +2.09% | +14.17% | +11.41% | +14.68% | +14.31% | -19.29% | -38.02% | -17.95% | 159B | |
| -0.05% | -1.06% | +13.56% | +23.59% | +19.51% | +35.11% | +55.54% | +170.51% | +473.28% | 137B | |
| +0.19% | -1.00% | +1.98% | +21.21% | +23.48% | +40.49% | +8.04% | -0.38% | +16.06% | 136B | |
| -0.57% | -1.88% | +3.14% | +3.57% | -7.14% | -9.30% | -22.13% | -12.34% | +11.21% | 107B | |
| +0.08% | -3.39% | -4.46% | -1.49% | +1.59% | +27.61% | +32.62% | +0.49% | -9.83% | 101B | |
| -1.71% | -1.40% | -2.23% | -12.40% | -16.13% | +6.21% | +56.05% | +62.97% | +549.11% | 72.33B | |
| -0.60% | +0.02% | +0.82% | +12.64% | +19.23% | +30.40% | +28.40% | +57.30% | +26.65% | 57.89B | |
| +0.76% | +1.16% | +2.06% | +39.60% | +32.50% | +76.02% | -2.97% | +4.02% | -48.90% | 55.49B | |
| -2.64% | -3.50% | -15.70% | -8.21% | -22.66% | -30.44% | +9.30% | +1.03% | +187.21% | 46.32B | |
| -0.35% | +1.40% | -0.11% | +9.36% | -1.76% | +1.46% | +13.08% | - | - | 43.98B | |
| Average | -0.53% | -1.53% | +1.61% | +10.35% | +8.37% | +23.05% | +31.39% | +56.95% | +198.24% | 240.85B | |
| Weighted average by Cap. | -0.76% | -2.93% | +2.04% | +11.31% | +11.34% | +33.45% | +54.64% | +117.63% | +422.73% |
- Stock Market
- Stocks
- AZN Stock
- 000982352 Stock
- Sector AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
